FGF23 and chronic kidney disease: Furthermore, studies examining the expression of proteins in bone tissue of patients with CKD stages 2 to stage 5 on dialysis and healthy individuals have shown that as serum calcium declines, serum alkaline phosphatase, FGF-23, PTH, and osteoprotegerin increase with progression of CKD [47].